News Release

Mangosteen juice could protect health in the obese

Peer-Reviewed Publication

BMC (BioMed Central)

Mangosteen juice has anti-inflammatory properties which could prove to be valuable in preventing the development of heart disease and diabetes in obese patients. A study, published in BioMed Central's open access Nutrition Journal, describes how the juice of the exotic 'superfruit' lowered levels of C-reactive protein.

Dr. Jay Udani, M.D. from Medicus Research, California, worked with a team of researchers to carry out a randomized, double-blind placebo controlled trial. He said, "For people drinking over half a liter of mangosteen juice a day, the degree of reduction in CRP levels was statistically significant – a reduction of 1.33mg/L compared to an increase of 0.9mg/L in the placebo group".

Inflammation, as measured here by CRP, is a predictor of cardiovascular disease and a precursor of metabolic syndrome. Reducing inflammation in obese people is a treatment goal, and a natural treatment may be preferable to other treatments which may carry the risk of side effect. According to Udani, "Further studies with a larger population are required to confirm and further define the benefits of this juice, which was safe at all dosages tested".

###

Notes to Editors

1. Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study.
Jay K Udani, Betsy B Singh, Marilyn L Barrett and Vijay J Singh
Nutrition Journal (in press)

During embargo, article available here: http://www.nutritionj.com/imedia/1675415107248352_article.pdf?random=692065

After the embargo, article available at journal website: http://www.nutritionj.com/

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication

2. Nutrition Journal is an open access, peer-reviewed, online journal that considers manuscripts within the field of human nutrition.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.